MétaCan
Menu
Retour à la cohorte
Enregistrement W1498820297 · doi:10.1111/ajt.12814

A Regulated System of Incentives for Living Kidney Donation: It Is Time for Opposing Groups to Have a Meaningful Dialogue!

2014· letter· en· W1498820297 sur OpenAlexaboutno aff
A. J. Matas, Rebecca Hays

Notice bibliographique

RevueAmerican Journal of Transplantation · 2014
Typeletter
Langueen
DomaineMedicine
ThématiqueOrgan Donation and Transplantation
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésScopusMedicineIncentiveDonationEconomic shortageOrgan donationKidney donationKidney transplantFamily medicineTransplantationKidney transplantationGerontologyIntensive care medicineMEDLINEInternal medicineLawPolitical science

Résumé

récupéré en direct d'OpenAlex

To the Editor: The shortage of organs is a crisis in clinical transplantation. In spite of numerous attempts to increase both living and deceased kidney donation rates in the United States, there has not been a change in the last 10 years. The combination of an increasing number of transplant candidates and no change in donation rates has resulted in increased waiting times and significant morbidity and mortality for those waiting. In the last 10 years, over sixty thousand candidates have been removed from the waiting list because of death or becoming too sick for undergoing transplantion (1http://optn.transplant.hrsa.gov/data. Data as of February 21, 2014. Accessed March 3, 2014.Google Scholar). A regulated system of incentives has the potential to increase living donation rates and thereby reduce transplant candidate morbidity and mortality. Despite the potential benefits to recipients, the concept of a trial of incentives remains controversial, with strong proponents and opponents (2Working Group on Incentives for Living DonationIncentives for organ donation: Proposed standards for an internationally acceptable system.Am J Transplant. 2012; 12: 306-312Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar, 3Matas AJ Hippen B Satel S In defense of a regulated system of compensation for living donation.Curr Opin Organ Transplant. 2008; 13: 379-385Crossref PubMed Scopus (50) Google Scholar, 4Matas AJ Design of a regulated system of compensation for living kidney donors.Clin Transplant. 2008; 22: 378-384Crossref PubMed Scopus (20) Google Scholar, 5Danovitch GM The high cost of organ transplant commercialism.Kidney Int. 2014; 85: 248-250Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar, 6Danovitch GM Chapman J Capron AM et al.Organ trafficking and transplant tourism: The role of global professional ethical standards-the 2008 Declaration of Istanbul.Transplantation. 2013; 95: 1306-1312Crossref PubMed Scopus (75) Google Scholar, 7Delmonico F Danovitch G Capron A Levin A Chapman J Council, Declaration of Istanbul Custodian Group, Montreal, QUE, Canada. “Proposed standards for incentives for organs donation” are neither international nor acceptable.Am J Transplant. 2012; 12: 1954-1955Abstract Full Text Full Text PDF PubMed Scopus (10) Google Scholar). Both groups have the same facts. Both agree that there is a shortage of organs; both favor removal of disincentives to donation; both likely agree that incentives may increase donation (only a trial will determine this) and that increased donation rates benefit patients and society. In addition, both are committed to the safety and well being of donors; both are opposed to unregulated underground markets and agree that such systems have done a disservice to donors and recipients. Yet, with these shared facts and opinions, there is a dichotomy of conclusions. Both groups believe that they are morally, ethically and in practice, correct. Why, given they share similar information, do opinions differ? A possible explanation can be found in Jonathan Haidt’s framework of individual morality being based on six principles (care/harm; liberty/oppression; fairness/cheating; loyalty/betrayal; sanctity/degradation and authority/subversion) and the relative importance given to each (8Haidt J The righteous mind: Why good people are divided by politics and religion.. Vintage Books, New York, NY2012Google Scholar). He suggests that these differences in emphasis lead to widely divergent conclusions. In the context of politics, he describes a “conservative moral matrix” (equal emphasis on each principle), a “liberal moral matrix” (strong emphasis on care/harm; liberty/oppression and fairness/cheating with little emphasis on the others) and a “libertarian moral matrix” (major emphasis on liberty/oppression). Importantly, the lack of appreciation of the source of the divergence of opinion results in: (a) each group neither understanding nor respecting the other’s perspective, and (b) inability to have a meaningful dialogue (8Haidt J The righteous mind: Why good people are divided by politics and religion.. Vintage Books, New York, NY2012Google Scholar). This same concept may be applicable to the impasse between groups in the discussion of living donor incentives, in which the difference between groups appears to be a matter of emphasis. First, proponents emphasize the potential benefit of a regulated system (for recipients), and use key words such as organ crisis, transplant candidate mortality and societal benefit. Opponents emphasize the potential risk to donors, and the impact that approving a system might have on society’s moral perspective, and, citing the harms of unregulated markets, use key words such as coercion, exploitation, undermining dignity, repugnance and commodification. Second, proponents emphasize local, structured trials in countries, such as the United States, capable of providing structure, regulation and transparency. Opponents emphasize developing a worldwide policy, and state that because many countries cannot provide regulation and transparency, incentives should be banned in all countries. Is there a way to move forward? Based on their perspective of the data, proponents suggest that a well-designed trial—in a country with effective systems in place for regulation and monitoring, and with appropriate entry criteria and end points—would answer the critical questions that determine whether or not a regulated system of incentives is worth exploring further (2Working Group on Incentives for Living DonationIncentives for organ donation: Proposed standards for an internationally acceptable system.Am J Transplant. 2012; 12: 306-312Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar). If a trial were to show increased donation rates but poor donor outcomes (health, psychosocial [social losses; regret]) compared to conventionally accepted donors, the system would be unacceptable, and scrapped. With their perspective, opponents identify—to date, theoretical—concerns about the impact on donors and aim for a global “one size fits all” policy. Worldwide, transplanters could and should agree that lack of effective regulation regarding living donation is dangerous to donors and recipients alike. At the same time, it needs to be recognized that as people die on the transplant waitlist, discounting a possible way to increase access to transplant without first testing its impact, outcomes, and pros/cons on donors and recipients is premature. Opting not to conduct a trial of a regulated system of incentives has real consequences—morbidity and mortality in those with end-stage renal disease; and, it could be argued further, exploits current living donors who (in the United States) incur significant financial burdens by donating (9Clarke KS Klarenbach S Vlaicu S et al.The direct and indirect costs incurred by living kidney donors—A systematic review.Nephrol Dial Transplant. 2006; 21: 1952-1960Crossref PubMed Scopus (97) Google Scholar). It is time for those with the full spectrum of opinions on the issue to have a meaningful dialogue. Given that the two groups share the same facts and the same concerns about donor safety, one possible way to initiate discussion is to narrow the field of focus. Perhaps, it should start with discussion as to whether or not, in a regulated system of incentives, both donor and recipient interests can be protected, and whether or not it is necessary to have a single global policy. If individual national policies are to be considered, the groups could discuss whether or not countries such as the United States, that can provide effective regulation and monitoring, and have maximized conventional donation, could consider trials of incentives in the context of the current impact of the organ shortage on their transplant candidates. The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,019
score de la tête « metaresearch » (Gemma)0,118
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,024
Score d'incertitude au seuil0,103

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0190,118
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0010,001
Études des sciences et des technologies0,0040,007
Communication savante0,0070,008
Science ouverte0,0050,002
Intégrité de la recherche0,0240,033
Charge utile insuffisante (le modèle a refusé de juger)0,0100,004

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,014
Tête enseignante GPT0,264
Écart entre enseignants0,249 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations5
Publié2014
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueAmerican Journal of TransplantationMême sujetOrgan Donation and TransplantationTravaux en français237 207